Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO
Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO
Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO
Submitted by
admin
on May 5, 2014 - 5:15pm
Source:
Fierce Biotech
News Tags:
IPOs
Bristol-Myers Squibb
Ambrx
Headline:
Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO
Do Not Allow Advertisers to Use My Personal information
